The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates

Withdrawn before enrolling

Conditions studied: Congenital Heart Disease

In brief

This is an observational, prospective study to evaluate the role of tranexamic acid in reducing blood transfusion in neonates undergoing cardiopulmonary bypass.

Key facts

Study ID

NCT01914211

Run by

Aymen N Naguib

People needed

0

Starts

2013-07-01

Expected to finish

2014-06-01

Last updated by the study team

2017-02-01

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All neonates undergoing arterial switch or aortic arch procedure utilizing cardiopulmonary bypass (CPB).

You may not qualify if…

• Jehovah's witness patients.

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.